Most EVALI Patients Used THC-Containing Products as New Cases Continue To Decline
Description
CDC today released two reports on e-cigarette, or vaping, product use-associated lung injury (EVALI), confirming that most EVALI patients report using tetrahydrocannabinol (THC)-containing products and that new EVALI cases have continued to decline